[{"address1": "1717 Langhorne Newtown Road", "address2": "Suite 300", "city": "Langhorne", "state": "PA", "zip": "19047", "country": "United States", "phone": "512 614 1848", "website": "https://www.savarapharma.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.", "fullTimeEmployees": 37, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew  Pauls J.D., M.B.A.", "age": 52, "title": "Chairman & CEO", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 970000, "exercisedValue": 0, "unexercisedValue": 5562470}, {"maxAge": 1, "name": "Mr. David L. Lowrance CPA", "age": 55, "title": "CFO, Chief Administrative Officer & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 667403, "exercisedValue": 0, "unexercisedValue": 1779407}, {"maxAge": 1, "name": "Mr. Robert  Lutz M.B.A.", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 723546, "exercisedValue": 0, "unexercisedValue": 142406}, {"maxAge": 1, "name": "Ms. Kate  McCabe J.D.", "title": "Senior VP & General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anne  Erickson", "age": 51, "title": "Chief Business Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Brian  Maurer", "title": "Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles  LaPree", "title": "Senior Vice President of Global Regulatory Affairs & Quality Assurance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  Clarke Ph.D.", "age": 63, "title": "Executive Vice President of Global Technical Operations", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raymond Dennis Pratt FACP, M.D.", "age": 72, "title": "Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 91889, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott L. Wilhoit", "age": 60, "title": "Executive Vice President of Global Commercial", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 1, "overallRisk": 5, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.41, "open": 4.4, "dayLow": 4.35, "dayHigh": 4.54, "regularMarketPreviousClose": 4.41, "regularMarketOpen": 4.4, "regularMarketDayLow": 4.35, "regularMarketDayHigh": 4.54, "beta": 0.957, "forwardPE": -10.809524, "volume": 583650, "regularMarketVolume": 583650, "averageVolume": 1778801, "averageVolume10days": 835030, "averageDailyVolume10Day": 835030, "bid": 4.48, "ask": 4.58, "bidSize": 100, "askSize": 200, "marketCap": 747288512, "fiftyTwoWeekLow": 3.115, "fiftyTwoWeekHigh": 5.7, "fiftyDayAverage": 4.391, "twoHundredDayAverage": 4.5214, "currency": "USD", "enterpriseValue": 630770688, "floatShares": 105421748, "sharesOutstanding": 164600992, "sharesShort": 8771947, "sharesShortPriorMonth": 7940310, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0533, "heldPercentInsiders": 0.04725, "heldPercentInstitutions": 0.92974, "shortRatio": 7.22, "shortPercentOfFloat": 0.064, "bookValue": 0.736, "priceToBook": 6.168478, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -75287000, "trailingEps": -0.42, "forwardEps": -0.42, "lastSplitFactor": "0:1", "lastSplitDate": 1493337600, "enterpriseToEbitda": -7.844, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "SVRA", "underlyingSymbol": "SVRA", "shortName": "Savara, Inc.", "longName": "Savara Inc.", "firstTradeDateEpochUtc": 1493386200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0ef43f0b-2e93-36b5-9cec-47503322ea03", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.54, "targetHighPrice": 16.0, "targetLowPrice": 7.0, "targetMeanPrice": 10.79, "targetMedianPrice": 10.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 121923000, "totalCashPerShare": 0.741, "ebitda": -80416000, "totalDebt": 26805000, "quickRatio": 10.893, "currentRatio": 11.314, "debtToEquity": 26.349, "returnOnAssets": -0.38796002, "returnOnEquity": -0.79481006, "freeCashflow": -40985752, "operatingCashflow": -71902000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]